SignatureFD’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-2,198
| Closed | -$34.6K | – | 3287 |
|
|
2024
Q1 | $34.6K | Hold |
2,198
| – | – | ﹤0.01% | 1736 |
|
|
2023
Q4 | $35.5K | Buy |
2,198
+653
| +42% | +$8.33K | ﹤0.01% | 1639 |
|
|
2023
Q3 | $19.7K | Sell |
1,545
-835
| -35% | -$11.5K | ﹤0.01% | 1858 |
|
|
2023
Q2 | $33.5K | Buy |
2,380
+673
| +39% | +$9.63K | ﹤0.01% | 1640 |
|
|
2023
Q1 | $26.4K | Sell |
1,707
-4
| -0.2% | -$67 | ﹤0.01% | 1714 |
|
|
2022
Q4 | $28K | Sell |
1,711
-16
| -0.9% | -$260 | ﹤0.01% | 1642 |
|
|
2022
Q3 | $32K | Buy |
1,727
+66
| +4% | +$1.04K | ﹤0.01% | 1517 |
|
|
2022
Q2 | $22K | Buy |
1,661
+1,007
| +154% | +$11.1K | ﹤0.01% | 1731 |
|
|
2022
Q1 | $6K | Sell |
654
-583
| -47% | -$4.96K | ﹤0.01% | 2447 |
|
|
2021
Q4 | $12K | Buy |
1,237
+554
| +81% | +$10.4K | ﹤0.01% | 2057 |
|
|
2021
Q3 | $23K | Buy |
+683
| New | +$21.8K | ﹤0.01% | 1706 |
|
|
2021
Q2 | – | Sell |
-85
| Closed | -$4K | – | 3092 |
|
|
2021
Q1 | $4K | Buy |
+85
| New | +$3.96K | ﹤0.01% | 2288 |
|
|
2020
Q3 | – | Sell |
-101
| Closed | -$6K | – | 2789 |
|
|
2020
Q2 | $6K | Buy |
101
+30
| +42% | +$1.6K | ﹤0.01% | 1763 |
|
|
2020
Q1 | $3K | Buy |
+71
| New | +$3.94K | ﹤0.01% | 1873 |
|
Other funds holding DCPH
SignatureFD's DCPH Position: Q2 2024 in Review
SignatureFD sold out of Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) in Q2 2024, closing a stake of 2,198 shares — an estimated $34.6K sold.
SignatureFD first reported a position in DCPH in Q1 2020 and held it in 14 quarters. The position peaked at $35.5K in Q4 2023. 1 fund tracked by Wall St. Rank holds DCPH as of Q2 2024.
- SignatureFD reported no remaining Deciphera Pharmaceuticals, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
- SignatureFD sold 2,198 Deciphera Pharmaceuticals, Inc. Common Stock shares in Q2 2024, an estimated $34.6K.
- SignatureFD first reported a position in Deciphera Pharmaceuticals, Inc. Common Stock in Q1 2020 and held it in 14 quarters.
- SignatureFD's Deciphera Pharmaceuticals, Inc. Common Stock position peaked at $35.5K in Q4 2023.
- 1 fund tracked by Wall St. Rank held Deciphera Pharmaceuticals, Inc. Common Stock as of Q2 2024.
Based on SignatureFD's 13F filing for Q2 2024, filed 29 Jul 2024.